References 1 Pantel K , Alix-Panabieres C . Circulating tumour cells in cancer patients : challenges and perspectives . Trends Molec Med 2010 ; 16 ( 9 ): 398 – 406 . 2 Merker JD et al . Circulating tumor DNA analysis in patients with cancer : American Society of Clinical Oncology and College of American Pathologists Joint Review . J Clin Oncol 2018 : Jco2017768671 . 3 Cristofanilli M et al . Circulating tumor cells , disease progression , and survival in metastatic breast cancer . N Engl J Med 2004 ; 351 ( 8 ): 781 – 91 . 4 Cohen SJ et al . Relationship of circulating tumor cells to tumor response , progression-free survival , and overall survival in patients with metastatic colorectal cancer . J Clin Oncol 2008 ; 26 ( 19 ): 3213 – 21 . 5 de Bono JS et al . Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer . Clin Cancer Res 2008 ; 14 ( 19 ): 6302 – 9 . 6 Zhang L et al . Meta-analysis of the prognostic value of circulating tumor cells in breast cancer . Clin Cancer Res 2012 ; 18 ( 20 ): 5701 – 10 . 7 Bidard FC et al . Clinical validity of circulating tumour cells in patients with metastatic breast cancer : a pooled analysis of individual patient data . Lancet Oncol 2014 ; 15 ( 4 ): 406 – 14 . 8 Baccelli I et al . Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay . Nat Biotechnol 2013 ; 31 ( 6 ): 539 – 44 . 9 Yang L et al . Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells . Biotechnol Bioeng 2009 ; 102 ( 2 ): 521 – 34 . 10 Lara O et al . Enrichment of rare cancer cells through depletion of normal cells using density and flowthrough , immunomagnetic cell separation . Exp Hemetol 2004 ; 32 ( 10 ): 891 – 904 . 11 Alix-Panabieres C , Mader S , Pantel K . Epithelial-mesenchymal plasticity in circulating tumor cells . J Molec Med ( Berlin , Germany ) 2017 ; 95 ( 2 ): 133 – 42 . 12 Powell AA et al . Single cell profiling of circulating tumor cells : transcriptional heterogeneity and diversity from breast cancer cell lines . PLoS One 2012 ; 7 ( 5 ): e33788 . 13 Giordano A et al . Epithelialmesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer . Mol Cancer Ther 2012 ; 11 ( 11 ): 2526 – 34 . 14 Ramirez P et al . Oncological evaluation by positron-emission tomography , circulating tumor cells and alpha fetoprotein in patients with hepatocellular carcinoma on the waiting list for liver transplantation . Transplant Proc 2016 ; 48 ( 9 ): 2962 – 5 . 15 Bredemeier M et al . Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment . Oncotarget 2016 ; 7 ( 27 ): 41677 – 90 . 16 Autebert J et al . High purity microfluidic sorting and analysis of circulating |
tumor cells : towards routine mutation detection . Lab Chip 2015 ; 15 ( 9 ): 2090 – 101 . 17 Karabacak NM et al . Microfluidic , marker-free isolation of circulating tumor cells from blood samples . Nat Protoc 2014 ; 9 ( 3 ): 694 – 710 . 18 Seal SH . Silicone flotation : a simple quantitative method for the isolation of free-floating cancer cells from the blood . Cancer 1959 ; 12 ( 3 ): 590 – 5 . 19 Desitter I et al . A new device for rapid isolation by size and characterization of rare circulating tumor cells . Anticancer Res 2011 ; 31 ( 2 ): 427 – 41 . 20 Farace F et al . A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas . Br J Cancer 2011 ; 105 ( 6 ): 847 – 53 . 21 Adams DL et al . The systematic study of circulating tumor cell isolation using lithographic microfilters . RSC Adv 2014 ; 9:4334 – 42 . 22 Adams DL et al . Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch (( R )) CTC test . Cytometry A 2015 ; 87 ( 2 ): 137 – 44 . 23 Xu L et al . Optimization and evaluation of a novel size based circulating tumor cell isolation system . PLoS One 2015 ; 10 ( 9 ): e0138032 . 24 Lemaire CA et al . Fast and label-free isolation of circulating tumor cells from blood : From a research microfluidic platform to an automated fluidic instrument , VTX-1 Liquid Biopsy System . SLAS Technol 2018 ; 23 ( 1 ): 16 – 29 . 25 Hou HW et al . Isolation and retrieval of circulating tumor cells using centrifugal forces . Sci Rep 2013 ; 3:1259 . 26 Balasubramanian P et al . Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream ( R ) system . PLoS One 2017 ; 12 ( 4 ): e0175414 . 27 Ilie M et al . “ Sentinel ” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease . PloS One 2014 ; 9 ( 10 ): e111597 . 28 Vona G et al . Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells . Am J Pathol 2000 ; 156 ( 1 ): 57 – 63 . 29 Harouaka RA et al . Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells . Clin Chem 2014 ; 60 ( 2 ): 323 – 33 . 30 Sarioglu AF et al . A microfluidic device for label-free , physical capture of circulating tumor cell clusters . Nat Methods 2015 ; 12 ( 7 ): 685 – 91 . 31 Krivacic RT et al . A rare-cell detector for cancer . Proc Natl Acad Sci U S A 2004 ; 101 ( 29 ): 10501 – 4 . 32 Somlo G et al . Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced / inflammatory , and stage IV breast cancer , using a novel detection technology . Breast Cancer Res Treat 2011 ; 128 ( 1 ): 155 – 63 . 33 Ntouroupi TG et al . Detection of circulating tumour cells |
in peripheral blood with an automated scanning fluorescence microscope . Br J Cancer 2008 ; 99 ( 5 ): 789 – 95 . 34 Pailler E et al . Method for semi-automated microscopy of filtration-enriched circulating tumor cells . BMC Cancer 2016 ; 16:477 . 35 Lustberg MB et al . Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients . Breast Cancer Res 2014 ; 16 ( 2 ): R23 . 36 Zhang L et al . The identification and characterization of breast cancer CTCs competent for brain metastasis . Sci Transl Med 2013 ; 5 ( 180 ): 180ra48 . 37 Heitzer E et al . Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing . Cancer Res 2013 ; 73 ( 10 ): 2965 – 75 . 38 Abonnenc M et al . Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip . Anal Chem 2013 ; 85 ( 17 ): 8219 – 24 . 39 Fabbri F et al . Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device : KRAS mutation status in pure CTCs . Cancer Lett 2013 ; 335 ( 1 ): 225 – 31 . 40 Mesquita B et al . Molecular analysis of single circulating tumour cells following long-term storage of clinical samples . Mol Oncol 2017 ; 11 ( 12 ): 1687 – 97 . 41 Paolillo C et al . Detection of activating estrogen receptor gene ( ESR1 ) mutations in single circulating tumor cells . Clin Cancer Res 2017 ; 23 ( 20 ): 6086 – 93 . 42 Peeters DJ et al . Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting . Br J Cancer 2013 ; 108 ( 6 ): 1358 – 67 . 43 Esmaeilsabzali H et al . Detection and isolation of circulating tumor cells : principles and methods . Biotechnol Adv 2013 ; 31 ( 7 ): 1063 – 84 . 44 Riethdorf S , Wikman H , Pantel K . Review : Biological relevance of disseminated tumor cells in cancer patients . Int J Cancer 2008 ; 123 ( 9 ): 1991 – 2006 . 45 Fehm T et al . Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells . Breast Cancer Res 2009 ; 11 ( 4 ): R59 . 46 Punnoose EA et al . Molecular biomarker analyses using circulating tumor cells . PLoS One 2010 ; 5 ( 9 ): e12517 . 47 Pantel K , Brakenhoff RH , Brandt B . Detection , clinical relevance and specific biological properties of disseminating tumour cells . Nat Rev Cancer 2008 ; 8 ( 5 ): 329 – 40 . 48 Chebouti I et al . ERCC1- expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting posttherapeutic outcome of ovarian cancer . Oncotarget 2017 ; 8 ( 15 ): 24303 – 13 . 49 Soler A et al . EpCAM- Independent enrichment and detection of viable circulating tumor cells using the EPISPOT |
assay . Methods Mol Biol 2017 ; 1634:263 – 76 . 50 Cayrefourcq L et al . Establishment and characterization of a cell line from human circulating colon cancer cells . Cancer Res 2015 ; 75 ( 5 ): 892 – 901 . 51 Deneve E et al . Capture of viable circulating tumor cells in the liver of colorectal cancer patients . Clin Chem 2013 ; 59 ( 9 ): 1384 – 92 . 52 Kuske A et al . Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients . Sci Rep 2016 ; 6:39736 . 53 Markou A et al . Multiplex gene expression profiling of in vivo isolated circulating tumor cells in high-risk prostate cancer patients . Clin Chem 2018 ; 64 ( 2 ): 297 – 306 . 54 Alix-Panabieres C . EPISPOT assay : detection of viable DTCs / CTCs in solid tumor patients . Recent Results Cancer Res 2012 ; 195:69 – 76 . 55 Tulley S et al . Vita-Assay method of enrichment and identification of circulating cancer cells / circulating tumor cells ( CTCs ). Methods Mol Biol 2016 ; 1406:107 – 19 . 56 Friedlander TW et al . Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer . Int J Cancer 2014 ; 134 ( 10 ): 2284 – 93 . 57 Lu J et al . Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients . Int J Cancer 2010 ; 126 ( 3 ): 669 – 83 . 58 Hodgkinson CL et al . Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer . Nat Med 2014 ; 20 ( 8 ): 897 – 903 . 59 Riethdorf S et al . Detection and HER2 expression of circulating tumor cells : prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial . Clin Cancer Res 2010 ; 16 ( 9 ): 2634 – 45 . 60 Jaeger BAS et al . The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer : A translational research project of a prospective randomized phase III trial . PLoS One 2017 ; 12 ( 6 ): e0173593 . 61 Topalian SL , Drake CG , Pardoll DM . Immune checkpoint blockade : a common denominator approach to cancer therapy . Cancer Cell 2015 ; 27 ( 4 ): 450 – 61 . 62 Mazel M et al . Frequent expression of PD-L1 on circulating breast cancer cells . Mol Oncol 2015 ; 9 ( 9 ): 1773 – 82 . 63 Paoletti C et al . Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms . Cancer Res 2018 ; 78 ( 4 ): 1110 – 22 . 64 Sho S et al . Precision oncology using a limited number of cells : optimization of whole genome amplification products for sequencing applications . BMC Cancer 2017 ; 17 ( 1 ): 457 . 65 Denis JA , Lacorte JM . Detection of RAS mutations in circulating tumor cells : applications in colorectal cancer and prospects . Ann Biol Clin ( Paris ) 2017 ; 75 ( 6 ): 607 – 18 . 66 Obermayr E et al . Circulating |
tumor cells : potential markers of minimal residual disease in ovarian cancer ? a study of the OVCAD consortium . Oncotarget 2017 ; 8 ( 63 ): 106415 – 28 . 67 Podolak J et al . Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer . Oncotarget 2017 ; 8 ( 42 ): 71447 – 55 . |
145 |
||||
HHE 2018 | hospitalhealthcare . com |